Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1261128
PUBLISHER: KBV Research | PRODUCT CODE: 1261128
LAMEA Antimicrobial Susceptibility Testing Market Size, Share & Industry Trends Analysis Report By Application, By Method, By Type, By End User, By Product, By Country and Growth Forecast, 2022 - 2028
PUBLISHED:
PAGES: 127 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa Antimicrobial Susceptibility Testing Market would witness market growth of 9.5% CAGR during the forecast period (2022-2028).
Antibacterial medications have a crucial role in preventing infectious diseases; nonetheless, drug abuse and overuse have contributed to the emergence of antibiotic resistance. Furthermore, it is difficult to limit the spread of infectious diseases when there is a delay in detecting hazardous bacteria. This places pressure on the key actors to produce accurate and effective test kits to treat patients more effectively.
AST also aids in the discovery of new antimicrobial medications by determining the susceptibility of existing or newly developed antimicrobial treatments against infection-causing microbes. While AST is a significant tool, it should not be the only consideration considered when establishing the optimal treatment approach for a patient. When picking the most appropriate antibiotic, examining the patient's allergies, kidney function, other medications, and general condition is necessary. AMR is a developing problem caused by microorganisms like bacteria, fungi, viruses, and parasites that have gained the ability to withstand the effects of medications such as antivirals, antibiotics, and antifungals.
In the United Arab Emirates (UAE), the national action plan (NAP) on antimicrobial resistance (AMR) was developed to explain the current national responses to AMR in the sectors of environmental protection, food safety, and human & animal health. In addition, technical subcommittees led the development and implementation of strategies and actions in certain domains, such as antimicrobial stewardship programs (ASP), surveillance, antimicrobial resistance (AMR) prevention & control, and infection prevention & control (IPC). These activities will be conducted along with other relevant ministries, authorities, organizations, research institutes, and comparison laboratories. As a result, AMR testing is gaining speed in the region, fueling the expansion of the antimicrobial resistance diagnostic market.
The Brazil market dominated the LAMEA Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $88.8 million by 2028. The Argentina market is experiencing a CAGR of 10% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 9.2% during (2022 - 2028).
Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments covered in the Report:
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology & Others
By Method
- Automated Susceptibility Testing Instruments
- Disk Diffusion
- Etest Method
- Agar Diffusion
- Genotyping Method
By Type
- Antibacterial
- Antifungal
- Antiparasitic
- Others
By End User
- Hospitals & Diagnostic centers
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Clinical Research Organizations
By Product
- Automated Laboratory Instruments
- Manual Laboratory Instruments
- Culture & Growth Media
- Consumables
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- BioMerieux S.A.
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Bruker Corporation
- Accelerate Diagnostics, Inc.
- HiMedia Laboratories Pvt. Ltd.
- F. Hoffmann-La Roche Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Antimicrobial Susceptibility Testing Market, by Application
- 1.4.2 LAMEA Antimicrobial Susceptibility Testing Market, by Method
- 1.4.3 LAMEA Antimicrobial Susceptibility Testing Market, by Type
- 1.4.4 LAMEA Antimicrobial Susceptibility Testing Market, by End User
- 1.4.5 LAMEA Antimicrobial Susceptibility Testing Market, by Product
- 1.4.6 LAMEA Antimicrobial Susceptibility Testing Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition &Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market
Chapter 4. LAMEA Antimicrobial Susceptibility Testing Market by Application
- 4.1 LAMEA Clinical Diagnostics Market by Country
- 4.2 LAMEA Drug Discovery & Development Market by Country
- 4.3 LAMEA Epidemiology & Others Market by Country
Chapter 5. LAMEA Antimicrobial Susceptibility Testing Market by Method
- 5.1 LAMEA Automated Susceptibility Testing Instruments Market by Country
- 5.2 LAMEA Disk Diffusion Market by Country
- 5.3 LAMEA Etest Method Market by Country
- 5.4 LAMEA Agar Diffusion Market by Country
- 5.5 LAMEA Genotyping Method Market by Country
Chapter 6. LAMEA Antimicrobial Susceptibility Testing Market by Type
- 6.1 LAMEA Antibacterial Market by Country
- 6.2 LAMEA Antifungal Market by Country
- 6.3 LAMEA Antiparasitic Market by Country
- 6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Susceptibility Testing Market by End User
- 7.1 LAMEA Hospitals & Diagnostic centers Market by Country
- 7.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
- 7.3 LAMEA Research & Academic Institutes Market by Country
- 7.4 LAMEA Clinical Research Organizations Market by Country
Chapter 8. LAMEA Antimicrobial Susceptibility Testing Market by Product
- 8.1 LAMEA Automated Laboratory Instruments Market by Country
- 8.2 LAMEA Manual Laboratory Instruments Market by Country
- 8.3 LAMEA Culture & Growth Media Market by Country
- 8.4 LAMEA Consumables Market by Country
Chapter 9. LAMEA Antimicrobial Susceptibility Testing Market by Country
- 9.1 Brazil Antimicrobial Susceptibility Testing Market
- 9.1.1 Brazil Antimicrobial Susceptibility Testing Market by Application
- 9.1.2 Brazil Antimicrobial Susceptibility Testing Market by Method
- 9.1.3 Brazil Antimicrobial Susceptibility Testing Market by Type
- 9.1.4 Brazil Antimicrobial Susceptibility Testing Market by End User
- 9.1.5 Brazil Antimicrobial Susceptibility Testing Market by Product
- 9.2 Argentina Antimicrobial Susceptibility Testing Market
- 9.2.1 Argentina Antimicrobial Susceptibility Testing Market by Application
- 9.2.2 Argentina Antimicrobial Susceptibility Testing Market by Method
- 9.2.3 Argentina Antimicrobial Susceptibility Testing Market by Type
- 9.2.4 Argentina Antimicrobial Susceptibility Testing Market by End User
- 9.2.5 Argentina Antimicrobial Susceptibility Testing Market by Product
- 9.3 UAE Antimicrobial Susceptibility Testing Market
- 9.3.1 UAE Antimicrobial Susceptibility Testing Market by Application
- 9.3.2 UAE Antimicrobial Susceptibility Testing Market by Method
- 9.3.3 UAE Antimicrobial Susceptibility Testing Market by Type
- 9.3.4 UAE Antimicrobial Susceptibility Testing Market by End User
- 9.3.5 UAE Antimicrobial Susceptibility Testing Market by Product
- 9.4 Saudi Arabia Antimicrobial Susceptibility Testing Market
- 9.4.1 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application
- 9.4.2 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method
- 9.4.3 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type
- 9.4.4 Saudi Arabia Antimicrobial Susceptibility Testing Market by End User
- 9.4.5 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product
- 9.5 South Africa Antimicrobial Susceptibility Testing Market
- 9.5.1 South Africa Antimicrobial Susceptibility Testing Market by Application
- 9.5.2 South Africa Antimicrobial Susceptibility Testing Market by Method
- 9.5.3 South Africa Antimicrobial Susceptibility Testing Market by Type
- 9.5.4 South Africa Antimicrobial Susceptibility Testing Market by End User
- 9.5.5 South Africa Antimicrobial Susceptibility Testing Market by Product
- 9.6 Nigeria Antimicrobial Susceptibility Testing Market
- 9.6.1 Nigeria Antimicrobial Susceptibility Testing Market by Application
- 9.6.2 Nigeria Antimicrobial Susceptibility Testing Market by Method
- 9.6.3 Nigeria Antimicrobial Susceptibility Testing Market by Type
- 9.6.4 Nigeria Antimicrobial Susceptibility Testing Market by End User
- 9.6.5 Nigeria Antimicrobial Susceptibility Testing Market by Product
- 9.7 Rest of LAMEA Antimicrobial Susceptibility Testing Market
- 9.7.1 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application
- 9.7.2 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method
- 9.7.3 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type
- 9.7.4 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End User
- 9.7.5 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product
Chapter 10. Company Profiles
- 10.1 Bruker Corporation
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
- 10.1.5.1 Product Launches and Product Expansions:
- 10.1.5.2 Acquisition and Mergers:
- 10.2 BioMerieux S.A.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expenses
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Acquisition and Mergers:
- 10.2.5.2 Approvals and Trials:
- 10.3 Becton, Dickinson and Company
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
- 10.3.5.1 Partnerships, Collaborations, and Agreements:
- 10.4 Accelerate Diagnostics, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Product Launches and Product Expansions:
- 10.4.5.2 Approvals and Trials:
- 10.5 Thermo Fisher Scientific, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Product Launches and Product Expansions:
- 10.6 Danaher Corporation
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.7 Bio-Rad laboratories, Inc.
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 Recent strategies and developments:
- 10.7.5.1 Acquisition and Mergers:
- 10.8 Merck KGaA
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Segmental and Regional Analysis
- 10.8.4 Research & Development Expense
- 10.9 F. Hoffmann-La Roche Ltd.
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Segmental and Regional Analysis
- 10.9.4 Research & Development Expense
- 10.10. HiMedia Laboratories Pvt. Ltd.
- 10.10.1 Company Overview
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Antimicrobial Susceptibility Testing Market, by Application
- 1.4.2 LAMEA Antimicrobial Susceptibility Testing Market, by Method
- 1.4.3 LAMEA Antimicrobial Susceptibility Testing Market, by Type
- 1.4.4 LAMEA Antimicrobial Susceptibility Testing Market, by End User
- 1.4.5 LAMEA Antimicrobial Susceptibility Testing Market, by Product
- 1.4.6 LAMEA Antimicrobial Susceptibility Testing Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition &Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market
Chapter 4. LAMEA Antimicrobial Susceptibility Testing Market by Application
- 4.1 LAMEA Clinical Diagnostics Market by Country
- 4.2 LAMEA Drug Discovery & Development Market by Country
- 4.3 LAMEA Epidemiology & Others Market by Country
Chapter 5. LAMEA Antimicrobial Susceptibility Testing Market by Method
- 5.1 LAMEA Automated Susceptibility Testing Instruments Market by Country
- 5.2 LAMEA Disk Diffusion Market by Country
- 5.3 LAMEA Etest Method Market by Country
- 5.4 LAMEA Agar Diffusion Market by Country
- 5.5 LAMEA Genotyping Method Market by Country
Chapter 6. LAMEA Antimicrobial Susceptibility Testing Market by Type
- 6.1 LAMEA Antibacterial Market by Country
- 6.2 LAMEA Antifungal Market by Country
- 6.3 LAMEA Antiparasitic Market by Country
- 6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Susceptibility Testing Market by End User
- 7.1 LAMEA Hospitals & Diagnostic centers Market by Country
- 7.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
- 7.3 LAMEA Research & Academic Institutes Market by Country
- 7.4 LAMEA Clinical Research Organizations Market by Country
Chapter 8. LAMEA Antimicrobial Susceptibility Testing Market by Product
- 8.1 LAMEA Automated Laboratory Instruments Market by Country
- 8.2 LAMEA Manual Laboratory Instruments Market by Country
- 8.3 LAMEA Culture & Growth Media Market by Country
- 8.4 LAMEA Consumables Market by Country
Chapter 9. LAMEA Antimicrobial Susceptibility Testing Market by Country
- 9.1 Brazil Antimicrobial Susceptibility Testing Market
- 9.1.1 Brazil Antimicrobial Susceptibility Testing Market by Application
- 9.1.2 Brazil Antimicrobial Susceptibility Testing Market by Method
- 9.1.3 Brazil Antimicrobial Susceptibility Testing Market by Type
- 9.1.4 Brazil Antimicrobial Susceptibility Testing Market by End User
- 9.1.5 Brazil Antimicrobial Susceptibility Testing Market by Product
- 9.2 Argentina Antimicrobial Susceptibility Testing Market
- 9.2.1 Argentina Antimicrobial Susceptibility Testing Market by Application
- 9.2.2 Argentina Antimicrobial Susceptibility Testing Market by Method
- 9.2.3 Argentina Antimicrobial Susceptibility Testing Market by Type
- 9.2.4 Argentina Antimicrobial Susceptibility Testing Market by End User
- 9.2.5 Argentina Antimicrobial Susceptibility Testing Market by Product
- 9.3 UAE Antimicrobial Susceptibility Testing Market
- 9.3.1 UAE Antimicrobial Susceptibility Testing Market by Application
- 9.3.2 UAE Antimicrobial Susceptibility Testing Market by Method
- 9.3.3 UAE Antimicrobial Susceptibility Testing Market by Type
- 9.3.4 UAE Antimicrobial Susceptibility Testing Market by End User
- 9.3.5 UAE Antimicrobial Susceptibility Testing Market by Product
- 9.4 Saudi Arabia Antimicrobial Susceptibility Testing Market
- 9.4.1 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application
- 9.4.2 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method
- 9.4.3 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type
- 9.4.4 Saudi Arabia Antimicrobial Susceptibility Testing Market by End User
- 9.4.5 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product
- 9.5 South Africa Antimicrobial Susceptibility Testing Market
- 9.5.1 South Africa Antimicrobial Susceptibility Testing Market by Application
- 9.5.2 South Africa Antimicrobial Susceptibility Testing Market by Method
- 9.5.3 South Africa Antimicrobial Susceptibility Testing Market by Type
- 9.5.4 South Africa Antimicrobial Susceptibility Testing Market by End User
- 9.5.5 South Africa Antimicrobial Susceptibility Testing Market by Product
- 9.6 Nigeria Antimicrobial Susceptibility Testing Market
- 9.6.1 Nigeria Antimicrobial Susceptibility Testing Market by Application
- 9.6.2 Nigeria Antimicrobial Susceptibility Testing Market by Method
- 9.6.3 Nigeria Antimicrobial Susceptibility Testing Market by Type
- 9.6.4 Nigeria Antimicrobial Susceptibility Testing Market by End User
- 9.6.5 Nigeria Antimicrobial Susceptibility Testing Market by Product
- 9.7 Rest of LAMEA Antimicrobial Susceptibility Testing Market
- 9.7.1 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application
- 9.7.2 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method
- 9.7.3 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type
- 9.7.4 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End User
- 9.7.5 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product
Chapter 10. Company Profiles
- 10.1 Bruker Corporation
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
- 10.1.5.1 Product Launches and Product Expansions:
- 10.1.5.2 Acquisition and Mergers:
- 10.2 BioMerieux S.A.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expenses
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Acquisition and Mergers:
- 10.2.5.2 Approvals and Trials:
- 10.3 Becton, Dickinson and Company
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
- 10.3.5.1 Partnerships, Collaborations, and Agreements:
- 10.4 Accelerate Diagnostics, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Product Launches and Product Expansions:
- 10.4.5.2 Approvals and Trials:
- 10.5 Thermo Fisher Scientific, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Product Launches and Product Expansions:
- 10.6 Danaher Corporation
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.7 Bio-Rad laboratories, Inc.
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 Recent strategies and developments:
- 10.7.5.1 Acquisition and Mergers:
- 10.8 Merck KGaA
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Segmental and Regional Analysis
- 10.8.4 Research & Development Expense
- 10.9 F. Hoffmann-La Roche Ltd.
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Segmental and Regional Analysis
- 10.9.4 Research & Development Expense
- 10.10. HiMedia Laboratories Pvt. Ltd.
- 10.10.1 Company Overview
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Antimicrobial Susceptibility Testing Market, by Application
- 1.4.2 LAMEA Antimicrobial Susceptibility Testing Market, by Method
- 1.4.3 LAMEA Antimicrobial Susceptibility Testing Market, by Type
- 1.4.4 LAMEA Antimicrobial Susceptibility Testing Market, by End User
- 1.4.5 LAMEA Antimicrobial Susceptibility Testing Market, by Product
- 1.4.6 LAMEA Antimicrobial Susceptibility Testing Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition &Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market
Chapter 4. LAMEA Antimicrobial Susceptibility Testing Market by Application
- 4.1 LAMEA Clinical Diagnostics Market by Country
- 4.2 LAMEA Drug Discovery & Development Market by Country
- 4.3 LAMEA Epidemiology & Others Market by Country
Chapter 5. LAMEA Antimicrobial Susceptibility Testing Market by Method
- 5.1 LAMEA Automated Susceptibility Testing Instruments Market by Country
- 5.2 LAMEA Disk Diffusion Market by Country
- 5.3 LAMEA Etest Method Market by Country
- 5.4 LAMEA Agar Diffusion Market by Country
- 5.5 LAMEA Genotyping Method Market by Country
Chapter 6. LAMEA Antimicrobial Susceptibility Testing Market by Type
- 6.1 LAMEA Antibacterial Market by Country
- 6.2 LAMEA Antifungal Market by Country
- 6.3 LAMEA Antiparasitic Market by Country
- 6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Susceptibility Testing Market by End User
- 7.1 LAMEA Hospitals & Diagnostic centers Market by Country
- 7.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
- 7.3 LAMEA Research & Academic Institutes Market by Country
- 7.4 LAMEA Clinical Research Organizations Market by Country
Chapter 8. LAMEA Antimicrobial Susceptibility Testing Market by Product
- 8.1 LAMEA Automated Laboratory Instruments Market by Country
- 8.2 LAMEA Manual Laboratory Instruments Market by Country
- 8.3 LAMEA Culture & Growth Media Market by Country
- 8.4 LAMEA Consumables Market by Country
Chapter 9. LAMEA Antimicrobial Susceptibility Testing Market by Country
- 9.1 Brazil Antimicrobial Susceptibility Testing Market
- 9.1.1 Brazil Antimicrobial Susceptibility Testing Market by Application
- 9.1.2 Brazil Antimicrobial Susceptibility Testing Market by Method
- 9.1.3 Brazil Antimicrobial Susceptibility Testing Market by Type
- 9.1.4 Brazil Antimicrobial Susceptibility Testing Market by End User
- 9.1.5 Brazil Antimicrobial Susceptibility Testing Market by Product
- 9.2 Argentina Antimicrobial Susceptibility Testing Market
- 9.2.1 Argentina Antimicrobial Susceptibility Testing Market by Application
- 9.2.2 Argentina Antimicrobial Susceptibility Testing Market by Method
- 9.2.3 Argentina Antimicrobial Susceptibility Testing Market by Type
- 9.2.4 Argentina Antimicrobial Susceptibility Testing Market by End User
- 9.2.5 Argentina Antimicrobial Susceptibility Testing Market by Product
- 9.3 UAE Antimicrobial Susceptibility Testing Market
- 9.3.1 UAE Antimicrobial Susceptibility Testing Market by Application
- 9.3.2 UAE Antimicrobial Susceptibility Testing Market by Method
- 9.3.3 UAE Antimicrobial Susceptibility Testing Market by Type
- 9.3.4 UAE Antimicrobial Susceptibility Testing Market by End User
- 9.3.5 UAE Antimicrobial Susceptibility Testing Market by Product
- 9.4 Saudi Arabia Antimicrobial Susceptibility Testing Market
- 9.4.1 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application
- 9.4.2 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method
- 9.4.3 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type
- 9.4.4 Saudi Arabia Antimicrobial Susceptibility Testing Market by End User
- 9.4.5 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product
- 9.5 South Africa Antimicrobial Susceptibility Testing Market
- 9.5.1 South Africa Antimicrobial Susceptibility Testing Market by Application
- 9.5.2 South Africa Antimicrobial Susceptibility Testing Market by Method
- 9.5.3 South Africa Antimicrobial Susceptibility Testing Market by Type
- 9.5.4 South Africa Antimicrobial Susceptibility Testing Market by End User
- 9.5.5 South Africa Antimicrobial Susceptibility Testing Market by Product
- 9.6 Nigeria Antimicrobial Susceptibility Testing Market
- 9.6.1 Nigeria Antimicrobial Susceptibility Testing Market by Application
- 9.6.2 Nigeria Antimicrobial Susceptibility Testing Market by Method
- 9.6.3 Nigeria Antimicrobial Susceptibility Testing Market by Type
- 9.6.4 Nigeria Antimicrobial Susceptibility Testing Market by End User
- 9.6.5 Nigeria Antimicrobial Susceptibility Testing Market by Product
- 9.7 Rest of LAMEA Antimicrobial Susceptibility Testing Market
- 9.7.1 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application
- 9.7.2 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method
- 9.7.3 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type
- 9.7.4 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End User
- 9.7.5 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product
Chapter 10. Company Profiles
- 10.1 Bruker Corporation
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
- 10.1.5.1 Product Launches and Product Expansions:
- 10.1.5.2 Acquisition and Mergers:
- 10.2 BioMerieux S.A.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expenses
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Acquisition and Mergers:
- 10.2.5.2 Approvals and Trials:
- 10.3 Becton, Dickinson and Company
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
- 10.3.5.1 Partnerships, Collaborations, and Agreements:
- 10.4 Accelerate Diagnostics, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Product Launches and Product Expansions:
- 10.4.5.2 Approvals and Trials:
- 10.5 Thermo Fisher Scientific, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Product Launches and Product Expansions:
- 10.6 Danaher Corporation
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.7 Bio-Rad laboratories, Inc.
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 Recent strategies and developments:
- 10.7.5.1 Acquisition and Mergers:
- 10.8 Merck KGaA
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Segmental and Regional Analysis
- 10.8.4 Research & Development Expense
- 10.9 F. Hoffmann-La Roche Ltd.
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Segmental and Regional Analysis
- 10.9.4 Research & Development Expense
- 10.10. HiMedia Laboratories Pvt. Ltd.
- 10.10.1 Company Overview
LIST OF TABLES
- TABLE 1 LAMEA Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 2 LAMEA Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 3 LAMEA Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 4 LAMEA Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 5 LAMEA Clinical Diagnostics Market by Country, 2018 - 2021, USD Million
- TABLE 6 LAMEA Clinical Diagnostics Market by Country, 2022 - 2028, USD Million
- TABLE 7 LAMEA Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
- TABLE 8 LAMEA Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
- TABLE 9 LAMEA Epidemiology & Others Market by Country, 2018 - 2021, USD Million
- TABLE 10 LAMEA Epidemiology & Others Market by Country, 2022 - 2028, USD Million
- TABLE 11 LAMEA Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 12 LAMEA Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 13 LAMEA Automated Susceptibility Testing Instruments Market by Country, 2018 - 2021, USD Million
- TABLE 14 LAMEA Automated Susceptibility Testing Instruments Market by Country, 2022 - 2028, USD Million
- TABLE 15 LAMEA Disk Diffusion Market by Country, 2018 - 2021, USD Million
- TABLE 16 LAMEA Disk Diffusion Market by Country, 2022 - 2028, USD Million
- TABLE 17 LAMEA Etest Method Market by Country, 2018 - 2021, USD Million
- TABLE 18 LAMEA Etest Method Market by Country, 2022 - 2028, USD Million
- TABLE 19 LAMEA Agar Diffusion Market by Country, 2018 - 2021, USD Million
- TABLE 20 LAMEA Agar Diffusion Market by Country, 2022 - 2028, USD Million
- TABLE 21 LAMEA Genotyping Method Market by Country, 2018 - 2021, USD Million
- TABLE 22 LAMEA Genotyping Method Market by Country, 2022 - 2028, USD Million
- TABLE 23 LAMEA Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 24 LAMEA Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 25 LAMEA Antibacterial Market by Country, 2018 - 2021, USD Million
- TABLE 26 LAMEA Antibacterial Market by Country, 2022 - 2028, USD Million
- TABLE 27 LAMEA Antifungal Market by Country, 2018 - 2021, USD Million
- TABLE 28 LAMEA Antifungal Market by Country, 2022 - 2028, USD Million
- TABLE 29 LAMEA Antiparasitic Market by Country, 2018 - 2021, USD Million
- TABLE 30 LAMEA Antiparasitic Market by Country, 2022 - 2028, USD Million
- TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 33 LAMEA Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 34 LAMEA Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 35 LAMEA Hospitals & Diagnostic centers Market by Country, 2018 - 2021, USD Million
- TABLE 36 LAMEA Hospitals & Diagnostic centers Market by Country, 2022 - 2028, USD Million
- TABLE 37 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
- TABLE 38 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
- TABLE 39 LAMEA Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
- TABLE 40 LAMEA Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
- TABLE 41 LAMEA Clinical Research Organizations Market by Country, 2018 - 2021, USD Million
- TABLE 42 LAMEA Clinical Research Organizations Market by Country, 2022 - 2028, USD Million
- TABLE 43 LAMEA Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 44 LAMEA Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 45 LAMEA Automated Laboratory Instruments Market by Country, 2018 - 2021, USD Million
- TABLE 46 LAMEA Automated Laboratory Instruments Market by Country, 2022 - 2028, USD Million
- TABLE 47 LAMEA Manual Laboratory Instruments Market by Country, 2018 - 2021, USD Million
- TABLE 48 LAMEA Manual Laboratory Instruments Market by Country, 2022 - 2028, USD Million
- TABLE 49 LAMEA Culture & Growth Media Market by Country, 2018 - 2021, USD Million
- TABLE 50 LAMEA Culture & Growth Media Market by Country, 2022 - 2028, USD Million
- TABLE 51 LAMEA Consumables Market by Country, 2018 - 2021, USD Million
- TABLE 52 LAMEA Consumables Market by Country, 2022 - 2028, USD Million
- TABLE 53 LAMEA Antimicrobial Susceptibility Testing Market by Country, 2018 - 2021, USD Million
- TABLE 54 LAMEA Antimicrobial Susceptibility Testing Market by Country, 2022 - 2028, USD Million
- TABLE 55 Brazil Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 56 Brazil Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 57 Brazil Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 58 Brazil Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 59 Brazil Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 60 Brazil Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 61 Brazil Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 62 Brazil Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 63 Brazil Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 64 Brazil Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 65 Brazil Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 66 Brazil Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 67 Argentina Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 68 Argentina Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 69 Argentina Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 70 Argentina Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 71 Argentina Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 72 Argentina Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 73 Argentina Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 74 Argentina Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 75 Argentina Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 76 Argentina Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 77 Argentina Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 78 Argentina Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 79 UAE Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 80 UAE Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 81 UAE Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 82 UAE Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 83 UAE Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 84 UAE Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 85 UAE Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 86 UAE Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 87 UAE Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 88 UAE Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 89 UAE Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 90 UAE Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 91 Saudi Arabia Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 92 Saudi Arabia Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 93 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 94 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 95 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 96 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 97 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 98 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 99 Saudi Arabia Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 100 Saudi Arabia Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 101 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 102 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 103 South Africa Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 104 South Africa Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 105 South Africa Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 106 South Africa Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 107 South Africa Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 108 South Africa Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 109 South Africa Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 110 South Africa Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 111 South Africa Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 112 South Africa Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 113 South Africa Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 114 South Africa Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 115 Nigeria Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 116 Nigeria Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 117 Nigeria Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 118 Nigeria Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 119 Nigeria Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 120 Nigeria Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 121 Nigeria Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 122 Nigeria Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 123 Nigeria Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 124 Nigeria Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 125 Nigeria Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 126 Nigeria Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 127 Rest of LAMEA Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
- TABLE 128 Rest of LAMEA Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
- TABLE 129 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
- TABLE 130 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
- TABLE 131 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
- TABLE 132 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
- TABLE 133 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
- TABLE 134 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
- TABLE 135 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
- TABLE 136 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
- TABLE 137 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
- TABLE 138 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
- TABLE 139 Key Information - Bruker Corporation
- TABLE 140 Key information - BioMerieux S.A.
- TABLE 141 Key information - Becton, Dickinson and Company
- TABLE 142 Key Information - Accelerate Diagnostics, Inc.
- TABLE 143 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 144 Key Information - Danaher Corporation
- TABLE 145 Key Information - Bio-Rad Laboratories, Inc.
- TABLE 146 key Information - Merck KGaA
- TABLE 147 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
- TABLE 148 Key Information - HiMedia Laboratories Pvt. Ltd.
List of Figures
- FIG 1 Methodology for the research
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.